Key result
Huangqi Guizhi Wuwu Decoction protects against doxorubicin-induced cardiotoxicity via CDKN1A suppression and metabolic regulation.
Why the study?
Doxorubicin use is limited by dose-dependent cardiotoxicity with scarce effective interventions, and the mechanisms of Huangqi Guizhi Wuwu Decoction against this cardiotoxicity remain unexplored.
Answers are grounded in this paper and cite their sources.
Preclinical trial demonstrates that Huangqi Guizhi Wuwu Decoction attenuates doxorubicin cardiotoxicity in mice, suggesting therapeutic efficacy via CDKN1A downregulation.
The clinical utility of doxorubicin (DOX) is severely limited by dose-dependent cardiotoxicity, for which effective interventions remain scarce. Huangqi Guizhi Wuwu Decoction (HGWD) shows promising cardioprotective potential, but its mechanisms against DOX-induced cardiotoxicity (DIC) remain unexplored. This study explored the molecular mechanisms using an integrated metabolomics and transcriptomics approach. We identified 57 compounds in HGWD by liquid chromatography ion trap time-of-flight mass spectrometry (LC-IT-TOF/MS), and quantified five representative compounds for standardization. Mice were randomized into six groups: control, DOX (10 mg/kg × 2), DOX + low-dose HGWD (7 g/kg/d), DOX + high-dose HGWD (14 g/kg/d), DOX + dexrazoxane (100 mg/kg × 2), and HGWD (14 g/kg/d) alone. HGWD effectively alleviated cardiac dysfunction and reduced serum injury markers, with the high-dose group demonstrating efficacy comparable to the positive control drug, dexrazoxane. Subsequently, multi-omics profiling was performed on heart tissues from the control, DOX, and DOX + high-dose HGWD groups. Metabolomics identified 31 differential metabolites, highlighting energy metabolism restoration (e.g., acylcarnitines, citric acid) and inflammatory mediator modulation (e.g., arachidonic acid). Transcriptomics uncovered 37 genes enriched in innate immunity (e.g., Irf7, Isg15) and apoptosis (e.g., Bax, Cdkn1a). Network analysis constructed a core regulatory module, pinpointing CDKN1A as a potential mediator. Validation experiments confirmed that HGWD suppressed DOX-induced CDKN1A upregulation in mouse hearts. Furthermore, in H9c2 cells, HGWD mitigated DOX-induced apoptosis and inflammation, exhibiting cytoprotection comparable to pifithrin-α, a specific p53 inhibitor. In summary, HGWD protects against DIC by modulating a multi-target network and the suppression of CDKN1A represents a key underlying mechanism.
No takes yet. Share an insight, caveat, or question.
Hou et al. (2026) studied Doxorubicin-induced cardiotoxicity. Huangqi Guizhi Wuwu Decoction vs. Doxorubicin was evaluated. Integrated multi-omics analysis revealed that Huangqi Guizhi Wuwu Decoction protects against doxorubicin-induced cardiotoxicity through CDKN1A suppression and metabolic regulation.
Synapse has enriched 10 related papers. Consider them for comparative context: